Sigismond LASOCKI is a French professor of Anesthesiology and Critical Care Medicine. He is the head of Angers’ university hospital (1400 beds university hospital) Anesthesiology & Critical Care Department since 2013.
He was awarded his medical degree and MD at the University Denis Diderot, in Paris, France. He also passed his PhD at the INSERM in Paris. He is a member of the Metabolism, Endocrinology and Nutrition (MEN) and of the Perioperative Intensive Care (POIC) sections of the ESICM. He is a member of the board of director of the NATA. He is also one of the elected administrator of the SFAR (French society of Anesthesiology and critical care). He is a member of the ESA.
His areas of expertise are anemia and iron metabolism in critically ill and perioperative patients, trauma and antibiotherapy Stewardship. He develops a Patient Blood Management program at his institution, the OZeT program (“Objective Zero Transfusion”) and coordinated the recent French Guidelines for anemia management in the critically ill patients.
He has published over 160 journal articles, including numerous original papers and review articles regarding patient blood management and iron therapy. He served in the editorial board of intensive care medicine journal and has participated in numerous committees and scientific advisory boards. He is the investigators coordinator of two large ongoing RCT, sponsored by the French ministry of health, the HiFIT (Hip Fracture, Iron & Tranexamic acid study, NCT02972294) that evaluates the interest of intravenous iron and of Tranexamic Acid on transfusion rate in Hip Fracture patients (780 patients expected); and the MIVAR Trial (Milrinone Infusion for VAsospam Treatment in Subarachnoid hemorrhage, NCT04362527), that evaluates the interest of intravenous milrinone infusion to improve the outcome at 3 month in patients with vasospam following Subarachnoid hemorrhage (360 patients expected).